AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15713724
Drug: Oral Testosterone
RxNorm normalized name: testosterone Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Testosterone (T) 200, 400, or 800 mg in sesame oil with Dutasteride (D)
Trial: 15713724
Drug: Oral Testosterone
RxNorm normalized name: testosterone Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Testosterone Enanthate (TE) 200, 400, or 800 mg in sesame oil with Dutasteride (D)
Trial: 2111982
Drug: OKT3 monoclonal
RxNorm normalized name: factor VIII
DrugBank: Beroctocog alfa (DB14473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OKT3 monoclonal antibody (replacing cyclosporine during the first postoperative week)
Trial: 2111982
Drug: Conventional immunosuppression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional immunosuppression (cyclosporine, azathioprine, and steroids)
Trial: 25627152
Drug: Supervised exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised exercise therapy
Trial: 31728673
Drug: 2 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg/kg/day prednisone
Trial: 31728673
Drug: 1.5 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg/kg/day prednisone
Trial: 31728673
Drug: 1 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg/day prednisone
Trial: 31728673
Drug: Cumulative prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cumulative prednisone dose for 1.5 mg/kg/day
Trial: 31728673
Drug: Cumulative prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cumulative prednisone dose for 1 mg/kg/day
Trial: 31099599
Drug: MacConkey agar
RxNorm normalized name: Agar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MacConkey agar medium supplemented with 8 mg/L of ceftiofur (MC-CEF)
Trial: 20876366
Drug: Non-diuretic antihypertensive
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-diuretic antihypertensive treatment (Control)
Trial: 17202205
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy associated with systemic steroids (SS + PDT)
Trial: 2886822
Drug: Blood glucose
RxNorm normalized name: Blood Glucose Book
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood glucose maintained at 3.2 mmol/l
Trial: 20538327
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D insufficiency (defined as 25-hydroxyvitamin D level of 30 ng/mL or less)
Trial: 17083064
Drug: Losartan (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50-100 mg/d)
Trial: 1660550
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II infusion (5%, 10%, and 20% of the pressor dose)
Trial: 11437859
Drug: Lisinopril (ACE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (ACE inhibitor)
Trial: 6751131
Drug: Abstinence-oriented insight
RxNorm normalized name: Oriental melon
DrugBank: Muskmelon (DB15611)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abstinence-oriented insight group therapy
Trial: 6751131
Drug: Controlled drinking-oriented
RxNorm normalized name: Oriental melon
DrugBank: Muskmelon (DB15611)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled drinking-oriented behavioral modification group therapy
Trial: 11914029
Drug: rhGH administration
RxNorm normalized name: rhGH
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhGH administration
Trial: 29886113
Drug: Intralesional verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional verapamil (2.5 mg/mL)
Trial: 29886113
Drug: Intralesional triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intralesional triamcinolone acetonide (40 mg/mL)
Trial: 26357940
Drug: AFN-1252 100
RxNorm normalized name: AFN-1252
DrugBank: AFN-1252 (DB12658)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AFN-1252 100 mg
Trial: 23159479
Drug: 16 IU
RxNorm normalized name: QUATERNIUM-16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 IU of intranasal oxytocin
Trial: 25860107
Drug: Desvenlafaxine 50
RxNorm normalized name: desvenlafaxine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desvenlafaxine 50 mg/day
Trial: 16552801
Drug: 5'‐DFUR oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5'‐DFUR oral administration at the dose of 800‐1200 mg/d for 3 ‐ 5 d
Trial: 16552801
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg 5‐FU + 200 mg/d CF by venous drip for 3 ‐ 5 d
Trial: 14586743
Drug: Corticosteroid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid therapy (0.5 mg/kg per day of prednisolone)
Trial: 10756223
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate nasal spray (as-needed usage)
Trial: 1563463
Drug: Lisuride subcutaneous
RxNorm normalized name: lisuride
DrugBank: Lisuride (DB00589)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisuride subcutaneous infusion
Trial: 3909544
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Acyclovir ointment and Oral acyclovir)
Trial: 30284023
Drug: Lisinopril and
RxNorm normalized name: lisinopril and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril and losartan combination therapy
Trial: 19416259
Drug: Calcipotriol 50
RxNorm normalized name: Calcipotriol 50 microgram/g cutaneous cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol 50 microg mL(‐1) scalp solution - twice daily
Trial: 18001533
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg + amlodipine + benazepril
Trial: 9587047
Drug: Neoplanta capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoplanta capsule
Trial: 9587047
Drug: Sandimmune Neoral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sandimmune Neoral capsule
Trial: 11125309
Drug: Zidovudine treatment
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine treatment
Trial: 23136231
Drug: DD-MVAC (M
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DD-MVAC (M 30 mg/m(2), V 3 mg/m(2), A 30 mg/m(2), C 70 mg/m(2) q 2 weeks)
Trial: 23136231
Drug: DD-GC (G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DD-GC (G 2500 mg/m(2), C 70 mg/m(2) q 2 weeks)
Trial: 22177374
Drug: Intravenous MID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous MID administration
Trial: 22177374
Drug: Oral MID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral MID administration
Trial: 12622624
Drug: Narrowband UV-B
RxNorm normalized name: Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narrowband UV-B (TL-01) phototherapy 3 times weekly
Trial: 12622624
Drug: Oral 8-methoxypsoralen
RxNorm normalized name: 8-methoxypsoralen
DrugBank: Methoxsalen (DB00553)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral 8-methoxypsoralen photochemotherapy (8-MOP PUVA) twice weekly
Trial: 10954911
Drug: Low-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose interferon (5 x 10(6) U thrice weekly) plus vinblastine (6 mg/m2 every 14 days)
Trial: 10954911
Drug: High-dose interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose interferon monotherapy (15 x 10(6) U thrice weekly)
Trial: 9247766
Drug: Captopril 50
RxNorm normalized name: captopril 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 50 mg and Losartan 50 mg
Trial: 8325192
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of the same solution without Doppler investigation
Trial: 3568582
Drug: beta-blockade (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: beta-blockade (2 X 80 mg oral propranolol per day)
Trial: 29979799
Drug: Continuous Cryotherapy
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous Cryotherapy (CC)
Trial: 27632270
Drug: Nonsplinted implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsplinted implants
Trial: 15945304
Drug: Splinted implants
RxNorm normalized name: brilliant green
DrugBank: Brilliant green cation (DB11279)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Splinted implants
Trial: 7453623
Drug: Influenza vaccine
RxNorm normalized name: Influenza vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza vaccine A/Brazil/11/78
Trial: 26535968
Drug: 10, 20,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10, 20, 30, or 40 mg hydrocodone-ER (single dose)
Trial: 26535968
Drug: hydrocodone-ER (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hydrocodone-ER (single and multiple doses)
Trial: 17414929
Drug: FTC/TDF (200/300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FTC/TDF (200/300 mg once daily) for 7 days followed by GS-9137/r (50/100 mg once daily) and GS-9137/r plus FTC/TDF in a crossover fashion for 10 days.
Trial: 17414929
Drug: GS-9137/r (50/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GS-9137/r (50/100 mg once daily) alone.
Trial: 15384797
Drug: Once-weekly mupirocin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly mupirocin application (n = 18; men/women: 10/8; age: 55.3 ± 1.8 years)
Trial: 10511404
Drug: Ceftazidime i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime i.v. (1 g tid) + netilmicin i.v. (2 mg/kg bodyweight tid)
Trial: 10511404
Drug: Cefotaxime i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime i.v. (2 g tid) + netilmicin i.v. (2 mg/kg bodyweight tid)
Trial: 2037703
Drug: Guanfacine, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanfacine, 1 mg every night
Trial: 2037703
Drug: Methyldopa, 250
RxNorm normalized name: Methyldopa, 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyldopa, 250 mg tid
Trial: 31287757
Drug: Endovascular Treatment
RxNorm normalized name: Drug coated peripheral artery endovascular stent graft
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular Treatment (EVT) for M2 occlusions
Trial: 31287757
Drug: Endovascular Treatment
RxNorm normalized name: Drug coated peripheral artery endovascular stent graft
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular Treatment (EVT) for dominant M2 occlusions
Trial: 31287757
Drug: Endovascular Treatment
RxNorm normalized name: Drug coated peripheral artery endovascular stent graft
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular Treatment (EVT) for nondominant M2 occlusions
Trial: 31287757
Drug: Endovascular Treatment
RxNorm normalized name: Drug coated peripheral artery endovascular stent graft
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular Treatment (EVT) for M1 occlusions
Trial: 29567116
Drug: GFF MDI
RxNorm normalized name: MDI-P
DrugBank: 3,4-Methylenedioxy-N-isopropylamphetamine (DB06112)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GFF MDI 144/38.4, GFF MDI 18/9.6, GP MDI 144 μg
Trial: 29567116
Drug: GFF MDI
RxNorm normalized name: MDI-P
DrugBank: 3,4-Methylenedioxy-N-isopropylamphetamine (DB06112)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GFF MDI 36/9.6, GP MDI 36, FF MDI 9.6 μg
Trial: 29567116
Drug: GFF MDI
RxNorm normalized name: MDI-P
DrugBank: 3,4-Methylenedioxy-N-isopropylamphetamine (DB06112)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GFF MDI 144/38.4 μg
Trial: 26864369
Drug: Egg intake
RxNorm normalized name: EGG
DrugBank: Egg (DB10529)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Egg intake (1 additional egg (55 g)/d)
Trial: 26864369
Drug: Cholesterol intake
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholesterol intake (100 mg/d higher)
Trial: 17937567
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg once daily (q.d.) or 60 mg twice daily (b.i.d.)
Trial: 3107660
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg at bedtime
Trial: 8186350
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg at bedtime
Trial: 24849545
Drug: Mitotane as
RxNorm normalized name: Mitotane
DrugBank: Mitotane (DB00648)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitotane as a single agent
Trial: 22333737
Drug: FISH (group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FISH (group consuming fish 3-4 times weekly but avoiding meat and poultry)
Trial: 22333737
Drug: OMN (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OMN (control group consuming meat, fish, and poultry daily)
Trial: 11688936
Drug: Oral protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral protein energy supplements (120 mL sip feed, 3 times daily, 540 kcal, 22.5 g protein per day)
Trial: 11688936
Drug: Oral protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral protein energy supplements
Trial: 23950156
Drug: Travoprost plus
RxNorm normalized name: Travoprost
DrugBank: Travoprost (DB00287)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Travoprost plus timolol fixed combination (TTFC)
Trial: 23950156
Drug: Latanoprost plus
RxNorm normalized name: Latanoprost
DrugBank: Latanoprost (DB00654)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Latanoprost plus timolol fixed combination (LTFC)
Trial: 20582993
Drug: L-dopa/carbidopa/entacapone (LCE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-dopa/carbidopa/entacapone (LCE)
Trial: 10097930
Drug: Repaglinide (0.5-4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repaglinide (0.5-4 mg t.i.d.)
Trial: 10097930
Drug: Glyburide (1.75-10.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyburide (1.75-10.5 mg daily)
Trial: 2129490
Drug: All treatment
RxNorm normalized name: UNDECYLENIC ACID 8 g in 30 mL / TOLNAFTATE 1 g in 30 mL TOPICAL LIQUID [Fugal nall treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All treatment periods
Trial: 1867965
Drug: Disopyramide (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disopyramide (150 mg racemic drug administered intravenously)
Trial: 29382400
Drug: Ethanol (61%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (61% w/v) plus chlorhexidine gluconate (1.0% solution)
Trial: 22393376
Drug: Escitalopram 10
RxNorm normalized name: escitalopram 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram 10 mg daily for 4 weeks
Trial: 24580390
Drug: 15 µg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 µg/kg morphine with 0.125% levobupivacaine
Trial: 24580390
Drug: 7.5 µg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 µg/kg morphine with 0.125% levobupivacaine
Trial: 7929871
Drug: Zopolrestat (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zopolrestat (dose range 50 to 1200 mg)
Trial: 26683485
Drug: Paediatric chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paediatric chemotherapy protocol (UKALL2003)
Trial: 1677545
Drug: Vecuronium infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium infusion during isoflurane-narcotic-nitrous oxide anesthesia
Trial: 1677545
Drug: Vecuronium infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium infusion during halothane-narcotic-nitrous oxide anesthesia
Trial: 1677545
Drug: Vecuronium infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium infusion during narcotic-nitrous oxide anesthesia
Trial: 1677545
Drug: Recovery index
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recovery index after termination of vecuronium infusion
Trial: 6139572
Drug: Vasoactive intestinal
RxNorm normalized name: Vasoactive intestinal peptide
DrugBank: Vasoactive intestinal peptide (DB18634)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vasoactive intestinal peptide (VIP) administered intravenously at 6 pmol/kg/min for 15 min
Trial: 22527786
Drug: Dexamethasone 8
RxNorm normalized name: dexamethasone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 8 mg intravenously
Trial: 25990255
Drug: 1 mmol/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mmol/kg of KHCO3 daily for 3 months
Trial: 25990255
Drug: 1.5 mmol/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mmol/kg of KHCO3 daily for 3 months
Trial: 24483776
Drug: Self-reported recall
RxNorm normalized name: black imported fire ant allergenic extract
DrugBank: Solenopsis richteri (DB11026)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-reported recall of weight monitoring adherence (daily or more frequent weighing)
Trial: 9098478
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment in women Ct positive but affected by PID
Trial: 24428466
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg daily
Trial: 24428466
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg daily
Trial: 23406994
Drug: MA (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MA (160 mg po, bid) plus thalidomide (50 mg po, bid)
Trial: 23406994
Drug: MA (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MA (160 mg po, bid) alone
Trial: 15181652
Drug: Kava extract
RxNorm normalized name: Kava extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kava extract (300 mg; p.o.)
Trial: 2017519
Drug: mCPP (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mCPP (0.5 mg/kg)
Trial: 3568947
Drug: pirenzepine (PIR),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pirenzepine (PIR), 50 mg
Trial: 27064778
Drug: Lateral infrapatellar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lateral infrapatellar injection site
Trial: 17975480
Drug: Nonselective beta‐adrenergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonselective beta‐adrenergic blockers
Trial: 18281407
Drug: STEPPS plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: STEPPS plus treatment as usual
Trial: 12205648
Drug: Simvastatin (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (up to 80mg daily)
Trial: 8682007
Drug: Amlodipine 10
RxNorm normalized name: amlodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine 10 mg daily
Trial: 7142740
Drug: Topical steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical steroid formulated in a series of solutions and gels at 90% saturation
Trial: 18096708
Drug: Procalcitonin-guided therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procalcitonin-guided therapy
Trial: 16467656
Drug: Aliskiren (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren (300 mg)
Trial: 17322141
Drug: Telmisartan (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan (80 mg)
Trial: 17428017
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg gabapentin capsule
Trial: 3602221
Drug: Unilateral ECT
RxNorm normalized name: ECT-001 expanded cord blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unilateral ECT two times weekly
Trial: 3602221
Drug: Unilateral ECT
RxNorm normalized name: ECT-001 expanded cord blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unilateral ECT three times weekly
Trial: 30740964
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral medroxyprogesterone acetate (MPA) 500 mg/day / levonorgestrel-intrauterine system (LNG-IUS)
Trial: 23399553
Drug: Fluticasone 440
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone 440 mcg twice daily
Trial: 19514651
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (triptorelin 0.1 mg)
Trial: 28850308
Drug: Curcumin 500
RxNorm normalized name: curcumin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin 500 mg twice daily
Trial: 19536884
Drug: PF‐3512676 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF‐3512676 40 mg + DTIC (850 mg/m(2))
Trial: 19536884
Drug: DTIC (850
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTIC (850 mg/m(2)) alone
Trial: 19536884
Drug: PF‐3512676 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF‐3512676 10 mg
Trial: 19536884
Drug: PF‐3512676 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF‐3512676 40 mg
Trial: 16770284
Drug: 1000 kcal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 kcal daily intravenous supplement for 3 days, followed by a 400 kcal oral nutritional supplement for 7 days
Trial: 2882083
Drug: Bovine surfactant
RxNorm normalized name: Pegademase Bovine
DrugBank: Pegademase (DB00061)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bovine surfactant ('Surfactant TA') 100 mg/kg surfactant phospholipid
Trial: 25130401
Drug: Lumiliximab in
RxNorm normalized name: Lumiliximab
DrugBank: Lumiliximab (DB06162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lumiliximab in combination with fludarabine, cyclophosphamide and rituximab (FCR)